These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28606734)

  • 1. The interplay between histone deacetylases and rho kinases is important for cancer and neurodegeneration.
    Mertsch S; Krämer OH
    Cytokine Growth Factor Rev; 2017 Oct; 37():29-45. PubMed ID: 28606734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between histone deacetylases and autophagy--from cancer therapy to neurodegeneration.
    Trüe O; Matthias P
    Immunol Cell Biol; 2012 Jan; 90(1):78-84. PubMed ID: 22124372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear histone deacetylases are not required for global histone deacetylation during meiotic maturation in porcine oocytes.
    Endo T; Kano K; Naito K
    Biol Reprod; 2008 Jun; 78(6):1073-80. PubMed ID: 18305223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neuronal cells: epigenetic aspects.
    Kukucka J; Wyllie T; Read J; Mahoney L; Suphioglu C
    Biomol Concepts; 2013 Aug; 4(4):319-33. PubMed ID: 25436583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
    Konsoula Z; Barile FA
    J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias.
    D'Amato L; Dell'Aversana C; Conte M; Ciotta A; Scisciola L; Carissimo A; Nebbioso A; Altucci L
    Epigenetics; 2015; 10(1):6-18. PubMed ID: 25494542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylases as transducers and targets of nuclear signaling.
    Walkinshaw DR; Tahmasebi S; Bertos NR; Yang XJ
    J Cell Biochem; 2008 Aug; 104(5):1541-52. PubMed ID: 18425769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylases and cancer.
    Glozak MA; Seto E
    Oncogene; 2007 Aug; 26(37):5420-32. PubMed ID: 17694083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-associated coiled-coil kinase (ROCK) protein controls microtubule dynamics in a novel signaling pathway that regulates cell migration.
    Schofield AV; Steel R; Bernard O
    J Biol Chem; 2012 Dec; 287(52):43620-9. PubMed ID: 23093407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
    Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylases as targets for the treatment of human neurodegenerative diseases.
    D'Mello SR
    Drug News Perspect; 2009 Nov; 22(9):513-24. PubMed ID: 20072728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC Inhibitors--CHI's Third Annual Conference.
    Rosato RR
    IDrugs; 2010 Jan; 13(1):13-5. PubMed ID: 20024840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
    Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
    Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylases: complex transducers of nuclear signals.
    Johnson CA; Turner BM
    Semin Cell Dev Biol; 1999 Apr; 10(2):179-88. PubMed ID: 10441071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer.
    Chiaradonna F; Cirulli C; Palorini R; Votta G; Alberghina L
    Antioxid Redox Signal; 2015 Jul; 23(1):30-50. PubMed ID: 24483782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
    Li G; Jiang H; Chang M; Xie H; Hu L
    J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
    Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
    Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assay for inhibitory activity of histone deacetylase].
    Yoshida M
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Sensitive and Flexible Assay for Determining Histone Deacetylase 1 (HDAC1) Activity.
    Wu MY; Wu RC
    Methods Mol Biol; 2016; 1436():3-13. PubMed ID: 27246204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer activities of histone deacetylase inhibitors.
    Bolden JE; Peart MJ; Johnstone RW
    Nat Rev Drug Discov; 2006 Sep; 5(9):769-84. PubMed ID: 16955068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.